BNR
Burning Rock Biotech Ltd
NASDAQ: BNR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$17.00
+4.68% today
Updated 2026-04-30
Market cap
$222.76M
P/E ratio
—
P/S ratio
0.41x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$2 – $42
Volume
0.0M
Burning Rock Biotech Ltd (BNR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-10.30%
Operating margin
-9.53%
ROE
-9.92%
ROA
-4.02%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $111.17M | $-131.28M | 64.49% | -108.73% | -118.09% |
| 2018 | $208.87M | $-177.50M | 64.66% | -77.27% | -84.98% |
| 2019 | $381.68M | $-168.34M | 71.61% | -44.30% | -44.10% |
| 2020 | $429.90M | $-407.24M | 73.02% | -95.93% | -94.73% |
| 2021 | $507.86M | $-796.70M | 71.70% | -156.94% | -156.87% |
| 2022 | $563.24M | $-971.23M | 67.47% | -174.07% | -172.44% |
| 2023 | $537.43M | $-653.69M | 67.59% | -124.54% | -121.63% |
| 2024 | $515.82M | $-346.63M | 70.26% | -69.32% | -67.20% |
| 2025 | $524.87M | $-53.84M | 74.67% | -10.16% | -10.26% |